| Identification | |
| Name: | GW 501516 |
| Synonyms: | Aceticacid, [2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]-(9CI); |
| CAS: | 317318-70-0 |
| Molecular Formula: | C21H18F3NO3S2 |
| Molecular Weight: | 453.50 |
| InChI: | InChI=1/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27) |
| Molecular Structure: | ![(C21H18F3NO3S2) Aceticacid, [2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]-(...](https://img1.guidechem.com/chem/e/dict/124/317318-70-0.jpg) |
| Properties | |
| Density: | 1.426 g/cm3 |
| Refractive index: | 1.619 |
| Appearance: | white solid |
| Specification: |
GW 501516 (CAS NO.317318-70-0) is also named as GW-501516 ; 2-(4-((2-(4-(Trifluoromethyl)phenyl)-5-ethylthiazol-4-yl)methylthio)-2-methylphenoxy)acetic acid ; Acetic acid, (2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)-5-thiazolyl)methyl)thio)phenoxy)- . GW 501516 (CAS NO.317318-70-0) is white solid. |
| Usage: |
GW 501516 (CAS NO.317318-70-0) is an experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. It is also a cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARd agonist. |
| Safety Data | |
 |
|
